SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001140361-25-035713 from atai Life Sciences Luxembourg S.A. (CIK 0002081043)

atai Life Sciences Luxembourg S.A. (CIK 0002081043)
Date: Sept. 22, 2025 · CIK: 0002081043 · Accession: 0001140361-25-035713

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290446

Date
September 22, 2025
Author
ATAI LIFE SCIENCES LUXEMBOURG S.A.
Form
CORRESP
Company
atai Life Sciences Luxembourg S.A. (CIK 0002081043)

Letter

Re:

ATAI Life Sciences Luxembourg S.A. ATAI Life Sciences N.V. Prof. J.H. Bavincklaan 7 1183 AT Amstelveen The Netherlands

September 22, 2025

VIA EDGAR

United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010

Attention:

Tyler Howes

ATAI Life Sciences Luxembourg S.A. Registration Statement on Form S-4 File No. 333-290446

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, we hereby respectfully request acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-290446) (as amended, the “ Registration Statement ”) of ATAI Life Sciences Luxembourg S.A., so that such Registration Statement will be declared effective as of 4:00 p.m. on September 24, 2025, or as soon thereafter as practicable.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Nathan Ajiashvili at (212) 906-2916 or, in his absence, Brian Umanoff at (714) 755-8253.

Thank you for your assistance in this matter.

Very truly yours,
ATAI LIFE SCIENCES LUXEMBOURG S.A.

Show Raw Text
CORRESP
 1
 filename1.htm

 ATAI Life Sciences Luxembourg S.A.
 ATAI Life Sciences N.V.
 Prof. J.H. Bavincklaan 7
 1183 AT Amstelveen
 The Netherlands

 September 22, 2025

 VIA EDGAR

 United States Securities and Exchange Commission
 Division of Corporation Finance
 100 F Street, N.E.
 Washington, D.C. 20549-6010

 Attention:

 Tyler Howes

 Re:

 ATAI Life Sciences Luxembourg S.A.
 Registration Statement on Form S-4
 File No. 333-290446

 Ladies and Gentlemen:

 Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, we hereby respectfully request acceleration of the effective date of the Registration Statement on Form S-4 (File No.
 333-290446) (as amended, the “ Registration Statement ”) of ATAI Life Sciences Luxembourg S.A., so that such Registration Statement will be declared effective as of 4:00 p.m. on September 24, 2025, or as soon thereafter as practicable.

 Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Nathan Ajiashvili at (212) 906-2916 or, in his
 absence, Brian Umanoff at (714) 755-8253.

 Thank you for your assistance in this matter.

 Very truly yours,

 ATAI LIFE SCIENCES LUXEMBOURG S.A.

 By:

 / s/ Ryan Barrett

 Name:

 Ryan Barrett

 Title:

 General Counsel

 cc:

 Srinivas Rao, ATAI Life Sciences Luxembourg S.A.

 Cosmo Feilding-Mellen, Beckley Psytech Limited

 Nathan Ajiashvili, Latham & Watkins LLP

 Brian Umanoff, Latham & Watkins LLP

 David Bakst, Mayer Brown LLP